Patent ID: 7462637
Filing Date: 2008-12-09
Classification: A61K,A61P,C07D

Abstract:
1. A method for treating inflammation or an inflammatory condition selected from adult respiratory distress syndrome, shock, oxygen toxicity, multiple organ injury syndrome secondary to septicemia, multiple organ injury syndrome secondary to trauma, reperfusion injury of tissue due to cardiopulmonary bypass, myocardial infarction or use with thrombolysis agents, acute glomerulonephritis, vasculitis, reactive arthritis, dermatosis with acute inflammatory components, stroke, thermal injury, hemodialysis, leukapheresis, ulcerative colitis, necrotizing enterocolitis, granulocyte transfusion associated syndrome, psoriasis, organ/tissue transplant rejection, graft vs. host reactions, an autoimmune disease, asthma, or the toxic effects of cytokine therapy in a patient which comprises administering to said patient a therapeutically effective amount of a compound a compound of the formula I: wherein: R R R R R X is an oxygen or a sulfur atom; and Y is an oxygen or a sulfur atom; or a pharmaceutically acceptable salt thereof.